0000905718-17-000863.txt : 20171003 0000905718-17-000863.hdr.sgml : 20171003 20171003172722 ACCESSION NUMBER: 0000905718-17-000863 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171003 FILED AS OF DATE: 20171003 DATE AS OF CHANGE: 20171003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Heath-Chiozzi Margo CENTRAL INDEX KEY: 0001718112 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 171119291 MAIL ADDRESS: STREET 1: C/O CELLDEX THERAPEUTICS, INC. STREET 2: 53 FRONTAGE ROAD, SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 BUSINESS PHONE: 908-200-7500 MAIL ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 4 1 chiozzi_fm4oct32017.xml OWNERSHIP DOCUMENT X0306 4 2017-10-03 0 0000744218 Celldex Therapeutics, Inc. CLDX 0001718112 Heath-Chiozzi Margo C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 220 HAMPTON NJ 08827 0 1 0 0 SVP of Regulatory Affairs Incentive Stock Option (right to buy) 3.01 2017-10-03 4 A 0 75000 0 A 2018-10-03 2027-10-03 Common Stock 75000 75000 D Represents option granted by Issuer pursuant to its 2008 Stock Option and Incentive Plan. 25% vest on October 3, 2018 and the remainder vests quarterly (in equal amounts) over the subsequent 12 quarters. /s/ Sam Martin, attorney-in-fact for Margo Heath-Chiozzi 2017-10-03